White label ELPA - ClinicalTrials.eu

Study on Adjusting Chemotherapy with Carboplatin and Paclitaxel for Patients with Poor Prognostic Ovarian Cancer

Recruiting

3 1 1 1
Investigated Drugs:
Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Recruiting

2 1 1
Investigated Drugs:
- (S)-4,5-Dihydro-2-[2-Hydroxy-4-(3,6-Dioxaheptyloxy)Phenyl]-4-Methyl-4-Thiazolecarboxylic Acid
Study on the Effects of Iptacopan in Patients with Idiopathic Membranoproliferative Glomerulonephritis (IC-MPGN)

Recruiting

3 1
Investigated Diseases:
- Glomerulonephritis membranoproliferative
Investigated Drugs:
- Iptacopan Hydrochloride
- Iptacopan
+4
Study on Glioblastoma Recurrence: Comparing SonoCloud-9 with Carboplatin to Standard Treatments Lomustine or Temozolomide for Patients Undergoing Tumor Removal Surgery

Recruiting

3 1 1 1
Investigated Drugs:
+3
Study on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse

Recruiting

3 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
+5
Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Recruiting

3 1 1 1
Investigated Drugs:
- Docetaxel
- Telisotuzumab Vedotin
+10
Study on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure

Recruiting

2 1 1 1 1
Investigated Drugs:
- 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
- Venetoclax
Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

Recruiting

3 1 1
Investigated Drugs:
- Nivolumab
- Relatlimab
+5
Study of Debio 0123 and Temozolomide for Adults with Recurrent or Newly Diagnosed Glioblastoma

Recruiting

1 1 1 1
Investigated Diseases:
- Glioblastoma
Investigated Drugs:
Study Comparing Mosunetuzumab and Lenalidomide with Other Treatments for Patients with Relapsed or Refractory Marginal Zone Lymphoma

Recruiting

3 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies